Skip to main content
 

Isquaemia Biotech

A biotechnology company focused on developing new drug lines for the treatment of acute ischaemic stroke and central nervous system diseases, including Alzheimer’s, Parkinson’s and multiple sclerosis.

Apartado:

EBT 2018